Literature DB >> 1658734

Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages.

Y Shoji1, S Akhtar, A Periasamy, B Herman, R L Juliano.   

Abstract

The cellular uptake and intracellular distribution of methylphosphonate oligonucleotides (15 mers) has been examined using both 32P labeled and fluorescent labeled oligonucleotides. The cellular uptake process for methylphosphonate oligonucleotides is highly temperature dependent, with a major increase in uptake occurring between 15 and 20 degrees C. Most of the label which becomes cell associated at 37 degrees C cannot be removed by acid washing or trypsinization and thus seems to be within the cell. Visualization of rhodamine labeled methylphosphonate oligonucleotides using digital imaging fluorescence microscopy reveals a vesicular subcellular distribution suggestive of an endosomal localization. There was extensive co-localization of rhodamine labeled methylphosphonate oligonucleotides with fluorescein-dextran, an endosomal/lysosomal marker substance. The apparent endocytotic uptake of labeled methylphosphonate oligonucleotides could not be blocked by competition with unlabeled methylphosphonate or phosphodiester oligonucleotides, nor by ATP. This contrasts with the situation for radiolabeled phosphodiester oligonucleotides whose uptake can be completely blocked with unlabeled competitor. Uptake of phosphodiester oligonucleotides, but not of methylphosphonate oligonucleotides, could be blocked by acidification of the cytosol. These observations suggest that the pathway of cellular uptake of methylphosphonate oligonucleotides involves fluid phase or adsorbtive endocytosis, and is distinct from the uptake pathway for phosphodiester oligonucleotides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658734      PMCID: PMC328955          DOI: 10.1093/nar/19.20.5543

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

1.  Intracellular distribution of microinjected antisense oligonucleotides.

Authors:  J P Leonetti; N Mechti; G Degols; C Gagnor; B Lebleu
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

Review 2.  The ways of endocytosis.

Authors:  B van Deurs; O W Petersen; S Olsnes; K Sandvig
Journal:  Int Rev Cytol       Date:  1989

3.  Blebbing, free Ca2+ and mitochondrial membrane potential preceding cell death in hepatocytes.

Authors:  J J Lemasters; J DiGuiseppi; A L Nieminen; B Herman
Journal:  Nature       Date:  1987 Jan 1-7       Impact factor: 49.962

Review 4.  Oligonucleotide analogues as potential chemotherapeutic agents.

Authors:  G Zon
Journal:  Pharm Res       Date:  1988-09       Impact factor: 4.200

5.  Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.

Authors:  C C Smith; L Aurelian; M P Reddy; P S Miller; P O Ts'o
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

6.  Intracellular pH during "chemical hypoxia" in cultured rat hepatocytes. Protection by intracellular acidosis against the onset of cell death.

Authors:  G J Gores; A L Nieminen; B E Wray; B Herman; J J Lemasters
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

7.  Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

Authors:  L A Yakubov; E A Deeva; V F Zarytova; E M Ivanova; A S Ryte; L V Yurchenko; V V Vlassov
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

8.  Acidification of the cytosol inhibits endocytosis from coated pits.

Authors:  K Sandvig; S Olsnes; O W Petersen; B van Deurs
Journal:  J Cell Biol       Date:  1987-08       Impact factor: 10.539

9.  Kinetics of endosome acidification in mutant and wild-type Chinese hamster ovary cells.

Authors:  D J Yamashiro; F R Maxfield
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

10.  The fate of peptides pinocytosed by macrophages in vitro.

Authors:  B A Ehrenreich; Z A Cohn
Journal:  J Exp Med       Date:  1969-01-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides.

Authors:  R L Juliano; S Alahari; H Yoo; R Kole; M Cho
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

2.  Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides.

Authors:  J A Hughes; A I Aronsohn; A V Avrutskaya; R L Juliano
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

3.  Inhibition of gene transcription by purine rich triplex forming oligodeoxyribonucleotides.

Authors:  C Roy
Journal:  Nucleic Acids Res       Date:  1993-06-25       Impact factor: 16.971

Review 4.  Application of antisense DNA method for the study of molecular bases of brain function and behavior.

Authors:  S Ogawa; D W Pfaff
Journal:  Behav Genet       Date:  1996-05       Impact factor: 2.805

Review 5.  Antisense approaches to the gene therapy of cancer--'Recnac'.

Authors:  I Gibson
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

6.  Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.

Authors:  S Sei; Q E Yang; D O'Neill; K Yoshimura; K Nagashima; H Mitsuya
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Use of a Pteridine Moiety to Track DNA Uptake in Cells.

Authors:  Justin A Costa; Edgar Leal-Pinto; Scott C Henderson; Troy Zabel; Mary E Hawkins; Basil Hanss
Journal:  Pteridines       Date:  2013-08       Impact factor: 0.581

8.  Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor.

Authors:  Andrew J Hollins; Mustapha Benboubetra; Yadollah Omidi; Bernd H Zinselmeyer; Andreas G Schatzlein; Ijeoma F Uchegbu; Saghir Akhtar
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

9.  Interactions of phosphodiester and phosphorothioate oligonucleotides with intestinal epithelial Caco-2 cells.

Authors:  G F Beck; W J Irwin; P L Nicklin; S Akhtar
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

10.  Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics.

Authors:  Moizza Mansoor; Alirio J Melendez
Journal:  Gene Regul Syst Bio       Date:  2008-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.